{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:50:02Z","timestamp":1782337802225,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral mucositis remains a significant complication during cancer therapy with no effective treatment. Gold nanoparticles offer anti-inflammatory, antioxidant properties with low toxicity. This study systematically reviews the literature assessing gold nanoparticles in the management of oral mucositis in animal models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A literature search was undertaken using MEDLINE, Embase, PubMed, and Web of Science databases, using the format for Systematic Review Centre for Laboratory Animal Experimentation. Prior to the review, the protocol was registered in the systematic review register, PROSPERO (registration no. CRD42021272169). Outcome measures included ulceration, histopathological scores, inflammatory mediators, microbial growth, and pain. Study quality was analysed by SYRCLE risk-of-bias tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Only one study met the inclusion criteria, documenting reduction in ulceration, inflammatory, and oxidative biomarkers. Exposure to AuNPs prevented inflammatory response induced by 5-fluorouracil in oral mucosa of hamsters. However, a high risk of bias necessitates further research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This review identifies a potential therapeutic strategy for prevention and management of oral mucositis. It also provides future direction for gold nanoparticle research in oral mucositis; however, there is lack of sufficient evidence to derive any conclusion. Research with standardized parameters including nanoparticle size, capping agent, surface charge, and appropriate oral mucositis animal models will establish risk\u2013benefit balance and margin of safety for therapeutic use of gold nanoparticles for oral mucositis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-023-02425-9","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T07:02:42Z","timestamp":1706166162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness of gold nanoparticles in prevention and treatment of oral mucositis in animal models: a systematic review"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-6019","authenticated-orcid":false,"given":"Minati","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Schwass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pletzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jithendra","family":"Ratnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"issue":"3","key":"2425_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","volume":"66","author":"A Trotti","year":"2003","unstructured":"Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66(3):253\u201362.","journal-title":"Radiother Oncol"},{"issue":"10","key":"2425_CR2","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1007\/s00520-019-04893-z","volume":"27","author":"J Bowen","year":"2019","unstructured":"Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019;27(10):4023\u201333.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2425_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","volume":"68","author":"LS Elting","year":"2007","unstructured":"Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110\u201320.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"2425_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1601-0825.2010.01681.x","volume":"16","author":"ST Sonis","year":"2010","unstructured":"Sonis ST. New thoughts on the initiation of mucositis. Oral Dis. 2010;16(7):597\u2013600.","journal-title":"Oral Dis"},{"issue":"1","key":"2425_CR5","first-page":"21","volume":"2","author":"ST Sonis","year":"2004","unstructured":"Sonis ST. A biological approach to mucositis. J Support Oncol. 2004;2(1):21\u201332 discussion 5-6.","journal-title":"J Support Oncol."},{"key":"2425_CR6","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2425_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/154411130201300502","volume":"13","author":"ST Sonis","year":"2002","unstructured":"Sonis ST. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med. 2002;13(5):380\u20139.","journal-title":"Crit Rev Oral Biol Med"},{"issue":"4","key":"2425_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.oraloncology.2006.04.011","volume":"43","author":"RM Logan","year":"2007","unstructured":"Logan RM, Gibson RJ, Sonis ST, Keefe DM. Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol. 2007;43(4):395\u2013401.","journal-title":"Oral Oncol"},{"issue":"7","key":"2425_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4161\/cbt.7.7.6207","volume":"7","author":"RM Logan","year":"2008","unstructured":"Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther. 2008;7(7):1139\u201345.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"2425_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1368-8375(03)00148-9","volume":"40","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, O\u2019Donnell KE, Popat R, Bragdon C, Phelan S, Cocks D, et al. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol. 2004;40(2):170\u20136.","journal-title":"Oral Oncol"},{"issue":"sup1","key":"2425_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/21691401.2018.1446968","volume":"46","author":"MA Khan","year":"2018","unstructured":"Khan MA, Khan MJ. Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity. Artif Cells Nanomed Biotechnol. 2018;46(sup1):1149\u201358.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"23","key":"2425_CR12","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1002\/cncr.33161","volume":"126","author":"CC Reyes-Gibby","year":"2020","unstructured":"Reyes-Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, et al. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer. 2020;126(23):5124\u201336.","journal-title":"Cancer"},{"issue":"17","key":"2425_CR13","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.3390\/ijms22179474","volume":"22","author":"L Wei","year":"2021","unstructured":"Wei L, Wen XS, Xian CJ. Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways. Int J Mol Sci. 2021;22(17):9474.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2425_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4(4):277\u201384.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"2425_CR15","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423\u201331.","journal-title":"Cancer"},{"key":"2425_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.oraloncology.2019.05.013","volume":"95","author":"A Blakaj","year":"2019","unstructured":"Blakaj A, Bonomi M, Gamez ME, Blakaj DM. Oral mucositis in head and neck cancer: evidence-based management and review of clinical trial data. Oral Oncol. 2019;95:29\u201334.","journal-title":"Oral Oncol"},{"issue":"10","key":"2425_CR17","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1007\/s00520-019-04895-x","volume":"27","author":"S Elad","year":"2019","unstructured":"Elad S. The MASCC\/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles. Support Care Cancer. 2019;27(10):3929\u201331.","journal-title":"Support Care Cancer"},{"issue":"10","key":"2425_CR18","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1007\/s00520-019-04887-x","volume":"27","author":"N Yarom","year":"2019","unstructured":"Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, et al. Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines\u2014part 1: vitamins, minerals, and nutritional supplements. Support Care Cancer. 2019;27(10):3997\u20134010.","journal-title":"Support Care Cancer"},{"key":"2425_CR19","doi-asserted-by":"publisher","first-page":"104919","DOI":"10.1016\/j.archoralbio.2020.104919","volume":"119","author":"M Ala","year":"2020","unstructured":"Ala M, Mohammad Jafari R, Ala M, Agbele AT, Hejazi SM, Tavangar SM, et al. Sumatriptan alleviates radiation-induced oral mucositis in rats by inhibition of NF-kB and ERK activation, prevention of TNF-\u03b1 and ROS release. Arch Oral Biol. 2020;119:104919.","journal-title":"Arch Oral Biol"},{"key":"2425_CR20","doi-asserted-by":"publisher","first-page":"e0116799","DOI":"10.1371\/journal.pone.0116799","volume":"10","author":"A Ara\u00fajo","year":"2015","unstructured":"Ara\u00fajo A, Varela H, de Medeiros CAC, Brito G, Lima K, Moura L, et al. Azilsartan reduced TNF-\u03b1 and IL-1\u03b2 levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-\u03b1 in an oral mucositis model. PLoS One. 2015;10:e0116799.","journal-title":"PLoS One"},{"key":"2425_CR21","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1016\/j.csbj.2021.10.028","volume":"19","author":"H Xiao","year":"2021","unstructured":"Xiao H, Fan Y, Li Y, Dong J, Zhang S, Wang B, et al. Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice. Comput Struct Biotechnol J. 2021;19:5898\u2013910.","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"2425_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/smll.200400093","volume":"1","author":"EE Connor","year":"2005","unstructured":"Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325\u20137.","journal-title":"Small"},{"issue":"3","key":"2425_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/smll.201201528","volume":"9","author":"VV Sumbayev","year":"2013","unstructured":"Sumbayev VV, Yasinska IM, Garcia CP, Gilliland D, Lall GS, Gibbs BF, et al. Gold nanoparticles downregulate interleukin-1\u03b2-induced pro-inflammatory responses. Small. 2013;9(3):472\u20137.","journal-title":"Small"},{"issue":"1","key":"2425_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12951-018-0415-5","volume":"16","author":"S Zhu","year":"2018","unstructured":"Zhu S, Jiang X, Boudreau MD, Feng G, Miao Y, Dong S, et al. Orally administered gold nanoparticles protect against colitis by attenuating toll-like receptor 4- and reactive oxygen\/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice. J Nanobiotechnology. 2018;16(1):86.","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"2425_CR25","first-page":"91","volume":"48","author":"L Leonaviciene","year":"2012","unstructured":"Leonaviciene L, Kirdaite G, Bradunaite R, Vaitkiene D, Vasiliauskas A, Zabulyte D, et al. Effect of gold nanoparticles in the treatment of established collagen arthritis in rats. Med Lith. 2012;48(2):91\u2013101.","journal-title":"Med Lith"},{"issue":"5","key":"2425_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.arcmed.2020.04.015","volume":"51","author":"WC Ko","year":"2020","unstructured":"Ko WC, Shieh JM, Wu WB. P38 MAPK and Nrf2 activation mediated naked gold nanoparticle induced heme oxygenase-1 expression in rat aortic vascular smooth muscle cells. Arch Med Res. 2020;51(5):388\u201396.","journal-title":"Arch Med Res"},{"issue":"51","key":"2425_CR27","doi-asserted-by":"publisher","first-page":"77884","DOI":"10.1007\/s11356-022-21235-5","volume":"29","author":"H Saleh","year":"2022","unstructured":"Saleh H, Salama M, Hussein RM. Polyethylene glycol capped gold nanoparticles ameliorate renal ischemia\u2013reperfusion injury in diabetic mice through AMPK-Nrf2 signaling pathway. Environ Sci Pollut Res. 2022;29(51):77884\u2013907.","journal-title":"Environ Sci Pollut Res"},{"issue":"9","key":"2425_CR28","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3390\/ijms23094863","volume":"23","author":"H Nguyen","year":"2022","unstructured":"Nguyen H, Sangha S, Pan M, Shin DH, Park H, Mohammed AI, et al. Oxidative stress and chemoradiation-induced oral mucositis: a scoping review of in vitro, in vivo and clinical studies. Int J Mol Sci. 2022;23(9):4863.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2425_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/pharmaceutics12040304","volume":"12","author":"CJF Vilar","year":"2020","unstructured":"Vilar CJF, Ribeiro SB, de Ara\u00fajo AA, Guerra GCB, de Ara\u00fajoJ\u00fanior RF, Brito GAdC, et al. Effect of gold nanoparticle on 5-fluorouracil-induced experimental oral mucositis in hamsters. Pharmaceutics. 2020;12(4):304.","journal-title":"Pharmaceutics"},{"issue":"3","key":"2425_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.toxlet.2012.11.022","volume":"217","author":"R Coradeghini","year":"2013","unstructured":"Coradeghini R, Gioria S, Garcia CP, Nativo P, Franchini F, Gilliland D, et al. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol Lett. 2013;217(3):205\u201316.","journal-title":"Toxicol Lett"},{"issue":"5","key":"2425_CR31","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1021\/nn301282m","volume":"6","author":"KY Huang","year":"2012","unstructured":"Huang KY, Ma HL, Liu J, Huo SD, Kumar A, Wei T, et al. Size-Dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano. 2012;6(5):4483\u201393.","journal-title":"ACS Nano"},{"issue":"2","key":"2425_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/toxsci\/kft081","volume":"133","author":"K-T Kim","year":"2013","unstructured":"Kim K-T, Zaikova T, Hutchison JE, Tanguay RL. Gold nanoparticles disrupt zebrafish eye development and pigmentation. Toxicol Sci. 2013;133(2):275\u201388.","journal-title":"Toxicol Sci"},{"issue":"9","key":"2425_CR33","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1039\/C5SC00792E","volume":"6","author":"ZV Feng","year":"2015","unstructured":"Feng ZV, Gunsolus IL, Qiu TA, Hurley KR, Nyberg LH, Frew H, et al. Impacts of gold nanoparticle charge and ligand type on surface binding and toxicity to gram-negative and gram-positive bacteria. Chem Sci. 2015;6(9):5186\u201396.","journal-title":"Chem Sci"},{"issue":"10","key":"2425_CR34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jat.2865","volume":"33","author":"S Fraga","year":"2013","unstructured":"Fraga S, Faria H, Soares ME, Duarte JA, Soares L, Pereira E, et al. Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells. J Appl Toxicol. 2013;33(10):1111\u20139.","journal-title":"J Appl Toxicol"},{"issue":"4","key":"2425_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1021\/bc049951i","volume":"15","author":"CM Goodman","year":"2004","unstructured":"Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem. 2004;15(4):897\u2013900.","journal-title":"Bioconjugate Chem"},{"issue":"11","key":"2425_CR36","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00520-013-1942-0","volume":"21","author":"DB McGuire","year":"2013","unstructured":"McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3165\u201377.","journal-title":"Support Care Cancer"},{"issue":"1","key":"2425_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00520-012-1605-6","volume":"21","author":"C Migliorati","year":"2013","unstructured":"Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, et al. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):333\u201341.","journal-title":"Support Care Cancer"},{"issue":"11","key":"2425_CR38","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s00520-013-1847-y","volume":"21","author":"O Nicolatou-Galitis","year":"2013","unstructured":"Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3179\u201389.","journal-title":"Support Care Cancer"},{"issue":"1","key":"2425_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00520-012-1613-6","volume":"21","author":"O Nicolatou-Galitis","year":"2013","unstructured":"Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, et al. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):357\u201364.","journal-title":"Support Care Cancer"},{"issue":"12","key":"2425_CR40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/ani9121163","volume":"9","author":"M Ritskes-Hoitinga","year":"2019","unstructured":"Ritskes-Hoitinga M, van Luijk J. How can systematic reviews teach us more about the implementation of the 3Rs and animal welfare? Animals. 2019;9(12):1163.","journal-title":"Animals"},{"issue":"10","key":"2425_CR41","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1161\/hs1001.096009","volume":"32","author":"J Horn","year":"2001","unstructured":"Horn J, de Haan RJ, Vermeulen M, Luiten PGM, Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia. Stroke. 2001;32(10):2433\u20138.","journal-title":"Stroke"},{"issue":"1","key":"2425_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1472-6831-12-22","volume":"12","author":"M Panghal","year":"2012","unstructured":"Panghal M, Kaushal V, Kadayan S, Yadav JP. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health. 2012;12(1):22.","journal-title":"BMC Oral Health"},{"issue":"1","key":"2425_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.htct.2019.05.006","volume":"42","author":"P Perez","year":"2020","unstructured":"Perez P, Pati\u00f1o J, Estacio M, Pino J, Manzi E, Medina D. Bacteremia in pediatric patients with hematopoietic stem cell transplantation. Hematol Transfus Cell Ther. 2020;42(1):5\u201311.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"1","key":"2425_CR44","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1002\/ebm2.7","volume":"2","author":"RBM de Vries","year":"2015","unstructured":"de Vries RBM, Hooijmans CR, Langendam MW, van Luijk J, Leenaars M, Ritskes-Hoitinga M, et al. A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies. Evid Based Preclin Med. 2015;2(1):e00007.","journal-title":"Evid Based Preclin Med"},{"issue":"1","key":"2425_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1258\/la.2011.011087","volume":"46","author":"M Leenaars","year":"2012","unstructured":"Leenaars M, Hooijmans CR, van Veggel N, ter Riet G, Leeflang M, Hooft L, et al. A step-by-step guide to systematically identify all relevant animal studies. Lab Anim. 2012;46(1):24\u201331.","journal-title":"Lab Anim"},{"issue":"1","key":"2425_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11670-008-0044-x","volume":"27","author":"S-K Zhang","year":"2015","unstructured":"Zhang S-K, Zheng R, Chen Q, Zhang S, Sun X, Chen W. Oral cancer incidence and mortality in China, 2011. Chin J Cancer Res. 2015;27(1):44\u201351.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"2425_CR47","first-page":"8","volume":"13","author":"J Pizzorno","year":"2014","unstructured":"Pizzorno J. Glutathione! Integr Med (Encinitas). 2014;13(1):8\u201312.","journal-title":"Integr Med (Encinitas)"},{"issue":"9","key":"2425_CR48","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jop.12549","volume":"46","author":"A Cardona","year":"2017","unstructured":"Cardona A, Balouch A, Abdul MM, Sedghizadeh PP, Enciso R. Efficacy of chlorhexidine for the prevention and treatment of oral mucositis in cancer patients: a systematic review with meta-analyses. J Oral Pathol Med. 2017;46(9):680\u20138.","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"2425_CR49","doi-asserted-by":"publisher","first-page":"125008","DOI":"10.1117\/1.JBO.20.12.125008","volume":"20","author":"M Curra","year":"2015","unstructured":"Curra M, Pellicioli AC, Filho NA, Ochs G, Matte \u00da, Filho MS, et al. Photobiomodulation reduces oral mucositis by modulating NF-kB. J Biomed Opt. 2015;20(12):125008.","journal-title":"J Biomed Opt"},{"issue":"11","key":"2425_CR50","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.oraloncology.2014.08.001","volume":"50","author":"RV Lalla","year":"2014","unstructured":"Lalla RV, Choquette LE, Curley KF, Dowsett RJ, Feinn RS, Hegde UP, et al. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer. Oral Oncol. 2014;50(11):1098\u2013103.","journal-title":"Oral Oncol"},{"issue":"4","key":"2425_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/lsm.22349","volume":"47","author":"AF Oton-Leite","year":"2015","unstructured":"Oton-Leite AF, Silva GB, Morais MO, Silva TA, Leles CR, Valadares MC, et al. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg Med. 2015;47(4):296\u2013305.","journal-title":"Lasers Surg Med"},{"issue":"1","key":"2425_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics13010053","volume":"13","author":"SB Ribeiro","year":"2021","unstructured":"Ribeiro SB, de Ara\u00fajo AA, Oliveira MMB, Santos Silva AMD, da Silva-J\u00fanior AA, Guerra GCB, et al. Effect of dexamethasone-loaded PLGA nanoparticles on oral mucositis induced by 5-fluorouracil. Pharmaceutics. 2021;13(1):53.","journal-title":"Pharmaceutics"},{"issue":"5","key":"2425_CR53","doi-asserted-by":"publisher","first-page":"e0128763","DOI":"10.1371\/journal.pone.0128763","volume":"10","author":"L Wang","year":"2015","unstructured":"Wang L, Gu Z, Zhai R, Zhao S, Luo L, Li D, et al. Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials. PLoS One. 2015;10(5):e0128763.","journal-title":"PLoS One"},{"key":"2425_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.22203\/eCM.v023a13","volume":"23","author":"Y-J Huang","year":"2012","unstructured":"Huang Y-J, Shiau A-L, Chen S-Y, Chen Y-L, Wang C-R, Tsai C-Y, et al. Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering. Eur Cell Mater. 2012;23:170\u201381.","journal-title":"Eur Cell Mater"},{"issue":"2","key":"2425_CR55","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/art.22401","volume":"56","author":"CY Tsai","year":"2007","unstructured":"Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, Chang MY, et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum. 2007;56(2):544\u201354.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2425_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/antibiotics9030100","volume":"9","author":"SG Ali","year":"2020","unstructured":"Ali SG, Ansari MA, Alzohairy MA, Alomary MN, AlYahya S, Jalal M, et al. Biogenic gold nanoparticles as potent antibacterial and antibiofilm nano-antibiotics against Pseudomonas aeruginosa. Antibiotics (Basel). 2020;9(3):100.","journal-title":"Antibiotics (Basel)"},{"issue":"128","key":"2425_CR57","doi-asserted-by":"publisher","first-page":"105551","DOI":"10.1039\/C5RA16305F","volume":"5","author":"K Giri","year":"2015","unstructured":"Giri K, Rivas Yepes L, Duncan B, Kolumam Parameswaran P, Yan B, Jiang Y, et al. Targeting bacterial biofilms via surface engineering of gold nanoparticles. RSC Adv. 2015;5(128):105551\u20139.","journal-title":"RSC Adv"},{"issue":"1","key":"2425_CR58","doi-asserted-by":"publisher","first-page":"26667","DOI":"10.1038\/srep26667","volume":"6","author":"Q Yu","year":"2016","unstructured":"Yu Q, Li J, Zhang Y, Wang Y, Liu L, Li M. Inhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells. Sci Rep. 2016;6(1):26667.","journal-title":"Sci Rep"},{"issue":"1","key":"2425_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/mutage\/gex027","volume":"33","author":"J Lebedov\u00e1","year":"2017","unstructured":"Lebedov\u00e1 J, Hedberg YS, Odnevall Wallinder I, Karlsson HL. Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry. Mutagenesis. 2017;33(1):77\u201385.","journal-title":"Mutagenesis"},{"issue":"5","key":"2425_CR60","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/smll.201502346","volume":"12","author":"M-C Senut","year":"2016","unstructured":"Senut M-C, Zhang Y, Liu F, Sen A, Ruden DM, Mao G. Size-dependent toxicity of gold nanoparticles on human embryonic stem cells and their neural derivatives. Small. 2016;12(5):631\u201346.","journal-title":"Small"},{"issue":"2","key":"2425_CR61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.nano.2012.06.002","volume":"9","author":"CA Simpson","year":"2013","unstructured":"Simpson CA, Salleng KJ, Cliffel DE, Feldheim DL. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine Nanotechnol Biolo Med. 2013;9(2):257\u201363.","journal-title":"Nanomedicine Nanotechnol Biolo Med"},{"issue":"5","key":"2425_CR62","doi-asserted-by":"publisher","first-page":"e36626","DOI":"10.1371\/journal.pone.0036626","volume":"7","author":"J Yaffe","year":"2012","unstructured":"Yaffe J, Montgomery P, Hopewell S, Shepard LD. Empty reviews: a description and consideration of Cochrane Systematic Reviews with No Included Studies. PLoS One. 2012;7(5):e36626.","journal-title":"PLoS One"},{"issue":"16","key":"2425_CR63","doi-asserted-by":"publisher","first-page":"1701460","DOI":"10.1002\/adhm.201701460","volume":"7","author":"M Laprise-Pelletier","year":"2018","unstructured":"Laprise-Pelletier M, Sim\u00e3o T, Fortin M-A. Gold nanoparticles in radiotherapy and recent progress in nanobrachytherapy. Adv Healthcare Mater. 2018;7(16):1701460.","journal-title":"Adv Healthcare Mater"},{"key":"2425_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2425_CR65","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4(4):303\u20136.","journal-title":"J Pharmacol Pharmacother"},{"issue":"6","key":"2425_CR66","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"key":"2425_CR67","doi-asserted-by":"publisher","first-page":"k760","DOI":"10.1136\/bmj.k760","volume":"360","author":"AJ Smith","year":"2018","unstructured":"Smith AJ, Clutton RE, Lilley E, Hansen KEA, Brattelid T. Improving animal research: PREPARE before you ARRIVE. BMJ. 2018;360:k760.","journal-title":"BMJ."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-023-02425-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T07:07:26Z","timestamp":1706166446000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02425-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2425"],"URL":"https:\/\/doi.org\/10.1186\/s13643-023-02425-9","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}